SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Autoimmune Disease

PUBLISHER: Polaris Market Research | PRODUCT CODE: 2109773

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 2109773

Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Type, By Product, By Test Type, By End User, and By Region - Market Forecast, 2026-2034

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global autoimmune disease diagnostics market size is expected to reach USD 7.18 Billion by 2034, according to a new study by Polaris Market Research. The report "Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Product, By Test Type, By End User, By Region - Market Forecast, 2026-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market focuses on the identification and management of autoimmune diseases through advanced diagnostic tools and techniques. Autoimmune diseases occur when the immune system attacks the body's tissues, leading to a range of chronic and potential conditions. The market encompasses diagnostic tests and technologies used to detect these conditions, including blood tests, imaging techniques, and molecular assays.

The increasing prevalence of autoimmune diseases globally drives demand for early and accurate diagnostic tools. As awareness of these conditions grows, patients and healthcare providers seek more precise and efficient diagnostic solutions. Additionally, the rising adoption of personalized medicine and advanced treatment approaches necessitates accurate diagnostics, further boosting market growth. Government initiatives and funding for research into autoimmune diseases and diagnostics are contributing to the development of new diagnostic methods, thereby enhancing market opportunities.

In 2021, the Accelerating Medicines Partnership (AMP) program introduced the Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) program. The AMP Autoimmune and Immune-Mediated Diseases (AMP AIM) initiative is driving the market by increasing awareness and promoting early screening for autoimmune diseases.

This market is experiencing swift to advanced and automated diagnostic solutions that provide higher accuracy and faster results. Integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is transforming how autoimmune diseases are detected and monitored, improving efficiency and precision. Furthermore, there is an increasing focus on developing noninvasive diagnostic techniques, which provide a more patient-friendly alternative to traditional methods.

In July 2022, KSL Beutner Laboratories (Beutner) announced the launch of an indirect immunofluorescence (IIF) serum blood test in the US. The test effectively detects laminin 332, an antigen linked to the persistent autoimmune condition mucous membrane pemphigoid (MMP). These increasing developments in diagnostic methods drive the industry.

Report Highlights

Based on type, the systemic autoimmune disease diagnostics segment dominated the market revenue share, mainly attributed to increased awareness among healthcare providers and patients.

The antinuclear antibody (ANA) tests segment, by test type, is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.

North America dominated the market due to advanced healthcare infrastructure and substantial funding for medical research and development.

Asia Pacific is expected to register the highest CAGR during the forecast period, owing to growing healthcare sectors in countries such as China and India and the increasing prevalence of autoimmune diseases.

A few global key players in the industry include Abbott; AESKU.DIAGNOSTICS; Beckman Coulter, Inc.; BIOMERIEUX; Bio-Rad Laboratories, Inc.; EUROIMMUN; F. Hoffmann-La Roche Ltd; Inova Diagnostics (Werfen Group); Myriad Genetics, Inc.; Quest Diagnostics; Scipher Medicine; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the autoimmune disease diagnostics market report on the basis of product, type, test type, end user, and region:

By Product Outlook (Revenue - USD Billion, 2021-2034)

Consumables and Assay Kits

Instruments

By Type Outlook (Revenue - USD Billion, 2021-2034)

Systemic Autoimmune Disease Diagnostics

Rheumatoid Arthritis

Ankylosing Spondylitis

Systemic Lupus Erythematosus (SLE)

Others

Localized Autoimmune Disease Diagnostics

Multiple Sclerosis

Type 1 Diabetes

Hashimoto's Thyroiditis

Idiopathic Thrombocytopenic Purpura

Others

By Test Type Outlook (Revenue - USD Billion, 2021-2034)

Antinuclear Antibody (ANA) Tests

Autoantibody Tests

Complete Blood Count (CBC)

Comprehensive Metabolic Panel

C-Reactive Protein (CRP)

Others

By End User Outlook (Revenue - USD Billion, 2021-2034)

Hospitals

Diagnostics Centers

Research Laboratories

By Regional Outlook (Revenue - USD Billion, 2021-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Australia

Vietnam

Malaysia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Show more
Product Code: PM1299

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Autoimmune Disease Diagnostics Market Insights

  • 4.1. Autoimmune Disease Diagnostics Market - Type Snapshot
  • 4.2. Autoimmune Disease Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Awareness and Screening Programs
      • 4.2.1.2. Rising Healthcare Expenditure and Investments in Research
  • 4.3. Restraints and Challenges
      • 4.3.1.1. Prolonged Turnaround Time for Results and Requirement for Multiple Diagnostic Tests
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers (Moderate)
    • 4.4.2. Threats of New Entrants (Low)
    • 4.4.3. Bargaining Power of Buyers (Moderate)
    • 4.4.4. Threat of Substitute (Moderate)
    • 4.4.5. Rivalry Among Existing Firms (High)
  • 4.5. PESTEL Analysis
  • 4.6. Autoimmune Disease Diagnostics Market Type Trends
  • 4.7. Value Chain Analysis
  • 4.8. COVID-19 Impact Analysis

5. Global Autoimmune Disease Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • 5.3. Consumables and Assay Kits
    • 5.3.1. Global Autoimmune Disease Diagnostics Market, by Consumables and Assay Kits, by Region, 2021-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Autoimmune Disease Diagnostics Market, by Instruments, by Region, 2021-2034 (USD Billion)

6. Global Autoimmune Disease Diagnostics Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • 6.3. Systemic Autoimmune Disease Diagnostics
    • 6.3.1. Global Autoimmune Disease Diagnostics Market, by Systemic Autoimmune Disease Diagnostics, by Region, 2021-2034 (USD Billion)
    • 6.3.2. Rheumatoid Arthritis
      • 6.3.2.1. Global Autoimmune Disease Diagnostics Market, by Rheumatoid Arthritis, by Region, 2021-2034 (USD Billion)
    • 6.3.3. Ankylosing Spondylitis
      • 6.3.3.1. Global Autoimmune Disease Diagnostics Market, by Ankylosing Spondylitis, by Region, 2021-2034 (USD Billion)
    • 6.3.4. Systemic Lupus Erythematosus (SLE)
      • 6.3.4.1. Global Autoimmune Disease Diagnostics Market, by Systemic Lupus Erythematosus (SLE), by Region, 2021-2034 (USD Billion)
    • 6.3.5. Others
      • 6.3.5.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2021-2034 (USD Billion)
  • 6.4. Localized Autoimmune Disease Diagnostics
    • 6.4.1. Global Autoimmune Disease Diagnostics Market, by Localized Autoimmune Disease Diagnostics, by Region, 2021-2034 (USD Billion)
    • 6.4.2. Multiple Sclerosis
      • 6.4.2.1. Global Autoimmune Disease Diagnostics Market, by Multiple Sclerosis, by Region, 2021-2034 (USD Billion)
    • 6.4.3. Type 1 Diabetes
      • 6.4.3.1. Global Autoimmune Disease Diagnostics Market, by Type 1 Diabetes, by Region, 2021-2034 (USD Billion)
    • 6.4.4. Hashimoto's Thyroiditis
      • 6.4.4.1. Global Autoimmune Disease Diagnostics Market, by Hashimoto's Thyroiditis, by Region, 2021-2034 (USD Billion)
    • 6.4.5. Idiopathic Thrombocytopenic Purpura
      • 6.4.5.1. Global Autoimmune Disease Diagnostics Market, by Idiopathic Thrombocytopenic Purpura, by Region, 2021-2034 (USD Billion)
    • 6.4.6. Others
      • 6.4.6.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2021-2034 (USD Billion)

7. Global Autoimmune Disease Diagnostics Market, by Test Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • 7.3. Antinuclear Antibody (ANA) Tests
    • 7.3.1. Global Autoimmune Disease Diagnostics Market, by Antinuclear Antibody (ANA) Tests, by Region, 2021-2034 (USD Billion)
  • 7.4. Autoantibody Tests
    • 7.4.1. Global Autoimmune Disease Diagnostics Market, by Autoantibody Tests, by Region, 2021-2034 (USD Billion)
  • 7.5. Complete Blood Count (CBC)
    • 7.5.1. Global Autoimmune Disease Diagnostics Market, by Complete Blood Count (CBC) , by Region, 2021-2034 (USD Billion)
  • 7.6. Comprehensive Metabolic Panel
    • 7.6.1. Global Autoimmune Disease Diagnostics Market, by Comprehensive Metabolic Panel, by Region, 2021-2034 (USD Billion)
  • 7.7. C-Reactive Protein (CRP)
    • 7.7.1. Global Autoimmune Disease Diagnostics Market, by C-Reactive Protein (CRP), by Region, 2021-2034 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2021-2034 (USD Billion)

8. Global Autoimmune Disease Diagnostics Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Autoimmune Disease Diagnostics Market, by Hospitals, by Region, 2021-2034 (USD Billion)
  • 8.4. Diagnostics Centers
    • 8.4.1. Global Autoimmune Disease Diagnostics Market, by Diagnostics Centers, by Region, 2021-2034 (USD Billion)
  • 8.5. Research Laboratories
    • 8.5.1. Global Autoimmune Disease Diagnostics Market, by Research Laboratories, by Region, 2021-2034 (USD Billion)

9. Global Autoimmune Disease Diagnostics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Autoimmune Disease Diagnostics Market Assessment, By Geography, 2021-2034 (USD Billion)
  • 9.3. Autoimmune Disease Diagnostics Market - North America
    • 9.3.1. North America: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
    • 9.3.2. North America: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
    • 9.3.3. North America: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
    • 9.3.4. North America: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.3.5. Autoimmune Disease Diagnostics Market - US
      • 9.3.5.1. US: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.3.5.2. US: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.3.5.3. US: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.3.5.4. US: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.3.6. Autoimmune Disease Diagnostics Market - Canada
      • 9.3.6.1. Canada: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.3.6.2. Canada: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.3.6.3. Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.3.6.4. Canada: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • 9.4. Autoimmune Disease Diagnostics Market - Europe
    • 9.4.1. Europe: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
    • 9.4.2. Europe: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
    • 9.4.3. Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
    • 9.4.4. Europe: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.5. Autoimmune Disease Diagnostics Market - UK
      • 9.4.5.1. UK: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.5.2. UK: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.5.3. UK: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.5.4. UK: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.6. Autoimmune Disease Diagnostics Market - France
      • 9.4.6.1. France: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.6.2. France: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.6.3. France: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.6.4. France: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.7. Autoimmune Disease Diagnostics Market - Germany
      • 9.4.7.1. Germany: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.7.2. Germany: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.7.3. Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.7.4. Germany: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.8. Autoimmune Disease Diagnostics Market - Italy
      • 9.4.8.1. Italy: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.8.2. Italy: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.8.3. Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.8.4. Italy: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.9. Autoimmune Disease Diagnostics Market - Spain
      • 9.4.9.1. Spain: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.9.2. Spain: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.9.3. Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.9.4. Spain: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.10. Autoimmune Disease Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.11. Autoimmune Disease Diagnostics Market - Russia
      • 9.4.11.1. Russia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.11.2. Russia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.11.3. Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.11.4. Russia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.4.12. Autoimmune Disease Diagnostics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • 9.5. Autoimmune Disease Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.5. Autoimmune Disease Diagnostics Market - China
      • 9.5.5.1. China: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.5.2. China: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.5.3. China: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.5.4. China: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.6. Autoimmune Disease Diagnostics Market - India
      • 9.5.6.1. India: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.6.2. India: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.6.3. India: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.6.4. India: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.7. Autoimmune Disease Diagnostics Market - Malaysia
      • 9.5.7.1. Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.8. Autoimmune Disease Diagnostics Market - Japan
      • 9.5.8.1. Japan: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.8.2. Japan: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.8.3. Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.8.4. Japan: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.9. Autoimmune Disease Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.10. Autoimmune Disease Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.10.2. South Korea: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.10.3. South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.10.4. South Korea: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.11. Autoimmune Disease Diagnostics Market - Australia
      • 9.5.11.1. Australia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.11.2. Australia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.11.3. Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.11.4. Australia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.5.12. Autoimmune Disease Diagnostics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • 9.6. Autoimmune Disease Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.6.5. Autoimmune Disease Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.6.6. Autoimmune Disease Diagnostics Market - UAE
      • 9.6.6.1. UAE: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.6.6.2. UAE: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.6.6.3. UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.6.6.4. UAE: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.6.7. Autoimmune Disease Diagnostics Market - Israel
      • 9.6.7.1. Israel: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.6.7.2. Israel: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.6.7.3. Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.6.7.4. Israel: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.6.8. Autoimmune Disease Diagnostics Market - South Africa
      • 9.6.8.1. South Africa: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.6.8.2. South Africa: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.6.8.3. South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.6.8.4. South Africa: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.6.9. Autoimmune Disease Diagnostics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • 9.7. Autoimmune Disease Diagnostics Market - Latin America
    • 9.7.1. Latin America: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
    • 9.7.2. Latin America: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
    • 9.7.3. Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
    • 9.7.4. Latin America: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.7.5. Autoimmune Disease Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.7.5.2. Mexico: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.7.5.3. Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.7.5.4. Mexico: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.7.6. Autoimmune Disease Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.7.6.2. Brazil: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.7.6.3. Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.7.6.4. Brazil: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.7.7. Autoimmune Disease Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.7.7.2. Argentina: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.7.7.3. Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.7.7.4. Argentina: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
    • 9.7.8. Autoimmune Disease Diagnostics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AESKU.DIAGNOSTICS
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Beckman Coulter, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BIOMERIEUX
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Bio-Rad Laboratories, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. EUROIMMUN
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. F. Hoffmann-La Roche Ltd
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Inova Diagnostics (Werfen Group)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Myriad Genetics, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Quest Diagnostics
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Scipher Medicine
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Siemens Healthcare Private Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Thermo Fisher Scientific Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
Show more
Product Code: PM1299

List of Tables:

  • Table 1 Global Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 2 Global Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 3 Global Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 4 Global Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 5 North America: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 6 North America: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 7 North America: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 8 North America: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 9 US: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 10 US: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 11 US: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 12 US: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 13 Canada: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 14 Canada: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 15 Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 16 Canada: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 17 Europe: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 18 Europe: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 19 Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 20 Europe: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 21 UK: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 22 UK: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 23 UK: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 24 UK: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 25 France: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 26 France: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 27 France: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 28 France: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 29 Germany: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 30 Germany: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 31 Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 32 Germany: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 33 Italy: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 34 Italy: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 35 Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 36 Italy: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 37 Spain: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 38 Spain: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 39 Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 40 Spain: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 41 Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 42 Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 43 Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 44 Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 45 Russia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 46 Russia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 47 Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 48 Russia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 49 Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 50 Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 51 Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 52 Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 53 Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 54 Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 55 Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 56 Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 57 China: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 58 China: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 59 China: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 60 China: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 61 India: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 62 India: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 63 India: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 64 India: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 65 Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 66 Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 67 Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 68 Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 69 Japan: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 70 Japan: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 71 Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 72 Japan: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 73 Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 74 Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 75 Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 76 Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 77 South Korea: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 78 South Korea: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 79 South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 80 South Korea: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 81 Australia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 82 Australia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 83 Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 84 Australia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 89 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 90 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 91 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 92 Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 93 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 94 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 95 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 96 Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 97 UAE: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 98 UAE: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 99 UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 100 UAE: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 101 Israel: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 102 Israel: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 103 Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 104 Israel: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 105 South Africa: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 106 South Africa: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 107 South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 108 South Africa: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 113 Latin America: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 114 Latin America: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 115 Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 116 Latin America: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 117 Mexico: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 118 Mexico: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 119 Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 120 Mexico: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 121 Brazil: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 122 Brazil: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 123 Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 124 Brazil: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 125 Argentina: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 126 Argentina: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 127 Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 128 Argentina: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)
  • Table 129 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2021-2034 (USD Billion)
  • Table 130 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2021-2034 (USD Billion)
  • Table 131 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2021-2034 (USD Billion)
  • Table 132 Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2021-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Autoimmune Disease Diagnostics Market, 2021-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Autoimmune Disease Diagnostics Market, by Product, 2025 & 2034 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Autoimmune Disease Diagnostics Market, by Type, 2025 & 2034 (USD Billion)
  • Figure 10. Market by Test Type
  • Figure 11. Global Autoimmune Disease Diagnostics Market, by Test Type, 2025 & 2034 (USD Billion)
  • Figure 12. Market by End User
  • Figure 13. Global Autoimmune Disease Diagnostics Market, by End User, 2025 & 2034 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!